Image For Activity Cover
Clinical Application and Importance of Highly Accurate LC-MS/MS Testing, and 25(OH)D2/25(OH)D3 Fractionation for Patient Management
Course Description
In partnership with Thermo Fisher Scientific, Endocrine Society presents a webinar on the clinical application and importance of highly accurate LC-MS/MS 25(OH)D2/25(OH)D3 vitamin D testing and D2/D3 fractionation for patient management. This activity is a platform through which clinicians and endocrinologists will receive further knowledge and training on LC-MS/MS technology.

  • Clinical Importance of More Highly Accurate Results in Testing | Dr. Daniel Bikle
  • Clinical Importance and Implications of D2 and D3 | Dr. Daniel Bikle
  • Implications of Highly Accurate LC-MS/MS 25(OH)D2/25(OH)D3 Vitamin D Testing on Patient Care and QoL | Dr. Glenville Jones
  • Analytical Review of the Guidelines for Highly Accurate LC-MS/MS 25(OH)D2/25(OH)D3 Vitamin D Testing | Dr. Glenville Jones
Target Audience
This educational initiative is intended for endocrinologists, clinicians, nurse practitioners, and physician assistants who will receive further knowledge and training on LC-MS/MS technology.
Learning Objectives
Upon completion of this activity, learners should be able to:
  • Describe the importance of proper patient classification for Vitamin D status
  • Analyze for serum Vitamin D status
  • Build awareness for availability of LC Tandem mass spectrometry
Faculty and Disclosures

Daniel Bikle, MD, PhD - Program Co-Chair
Veterans Affairs Medical Center and
University of California, San Francisco

Glenville Jones, PhD – Program Co-Chair
Queen’s University
Kingston, Ontario, Canada

STATEMENT OF INDEPENDENCE
As a provider of continuing medical education (CME) accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society's Special Programs Committee (SPC). The commercial supporter(s) of this activity have no influence over the planning of this activity.

DISCLOSURE POLICY
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.

The faculty reported the following relevant financial relationship(s) during the content development process for this activity:
  • Daniel Bilke, MD, PhD:  Grant Recipient, Radius Pharmaceutical
  •  

The faculty reported the no relevant financial relationship(s) during the content development process for this activity:

  • Glenville Jones, PhD

The following SPC member who planned and reviewed content for this activity reported no relevant financial relationships:

  • Kelly Lauter Roszko, MD, PhD

The following SPC Committee members reported financial relationships:

  • Andjela T. Drincic, MD: Advisory Board Member: Corcept

The following SPC members reported no relevant financial relationships:

Howard S. Blank, MD; Beret Ann Casey, MD; Lediya Cheru, MD; Marcelo Correia, MD, PhD; Angela M. Leung, MD; Kelly Lauter Roszko, MD, PhD; Virginia D. Sarapura, MD; Soleymani Taraneh, MD; and Savitha Subramanian, MD

The ES staff involved in the development of this CME activity reported no relevant financial relationships.

The Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable

 

ACKNOWLEDGEMENT OF COMMERCIAL SUPPORT 
This activity is supported by educational grants from Thermo Fisher Scientific.

Summary
Availability: On-Demand
Available Aug 31, 2021 to Aug 31, 2022
Cost: FREE
Credit Offered:
1 Participation Credit
Recommended
   
     EndoCareers | Contact Us | Privacy Policy | Terms of Use CONNECT WITH US                
       © 2021 Copyright Endocrine Society. All rights reserved.
2055 L Street NW, Suite 600 | Washington, DC 20036      
 202.971.3636 | 888.363.6274
      
   
Powered By